Epstein-Barr virus and multiple sclerosis: Cellular immune response and cross-reactivity

2010 ◽  
Vol 229 (1-2) ◽  
pp. 238-242 ◽  
Author(s):  
J. William Lindsey ◽  
Landon M. Hatfield
2005 ◽  
Vol 115 (5) ◽  
pp. 1352-1360 ◽  
Author(s):  
Sabine Cepok ◽  
Dun Zhou ◽  
Rajneesh Srivastava ◽  
Stefan Nessler ◽  
Susanne Stei ◽  
...  

Neurology ◽  
2004 ◽  
Vol 62 (12) ◽  
pp. 2277-2282 ◽  
Author(s):  
P. Sundstrom ◽  
P. Juto ◽  
G. Wadell ◽  
G. Hallmans ◽  
A. Svenningsson ◽  
...  

2019 ◽  
Vol 67 (3) ◽  
pp. 305-313
Author(s):  
David López-Valencia ◽  
Ángela Medina-Ortega ◽  
Diego Fernando Hoyos-Samboní ◽  
Jhan Sebastián Saavedra-Torres ◽  
Carolina Salguero

Introduction: Epstein-Barr virus is an infectious agent used to immortalize and induce polyclonal activation of B cells. It has been widely described that this virus produces changes in the cells it infects and in the immune response, and stimulates the development of autoimmune diseases.Objective: To characterize the association between Epstein-Barr virus and multiple sclerosis described in current scientific literature.Materials and methods: A 59-years range literature search was conducted in the PubMed, ScienceDirect, Redalyc and SciELO databases using the following MeSH terms: “Epstein-Barr virus, multiple sclerosis autoimmune diseases, autoimmune diseases of the nervous system”.Results: Many studies describe the association between Epstein-Barr virus and multiple sclerosis. It is believed that acute infection and viral reactivation promote the development of multiple sclerosis.Conclusions: It is necessary to conduct further research on the pathogenesis and morphophysiological and neuroimmunological changes –at the ecological, molecular, cellular, tissue, organic and systemic level– induced by the immune response and that favor the development of multiple sclerosis.


2012 ◽  
Vol 19 (3) ◽  
pp. 362-365 ◽  
Author(s):  
Giulio Disanto ◽  
Julia Pakpoor ◽  
Julia M Morahan ◽  
Carolina Hall ◽  
Ute C Meier ◽  
...  

Several lines of evidence support a role for Epstein–Barr virus (EBV) in the aetiology of multiple sclerosis (MS). This includes the observation that nearly all MS patients show serological markers of past EBV infection. Given the well-known association between MS prevalence and latitude, we investigated whether EBV seropositivity also increases with distance from the equator. We found that the proportion of EBV positive individuals is positively associated with latitude independently of MS status (odds ratio = 1.06, 95% CI = 1.02–1.09, p = 0.002). Latitude-related factors may be implicated in the immune response to EBV and its role in MS aetiology.


Author(s):  
Majid Teymoori-Rad ◽  
Mohammad Ali Sahraian ◽  
Talat Mokhtariazad ◽  
Ahmad Nejati ◽  
Razieh Sadat Kazemi Mozdabadi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document